Fig. 3: scRNAseq of cutaneous sarcoidosis and control skin samples. | Nature Communications

Fig. 3: scRNAseq of cutaneous sarcoidosis and control skin samples.

From: Inhibition of type 1 immunity with tofacitinib is associated with marked improvement in longstanding sarcoidosis

Fig. 3: scRNAseq of cutaneous sarcoidosis and control skin samples.

a UMAP projection of scRNA-seq data showing clustering of all cells, colored by cell type. b UMAP projection of scRNA-seq data in (a), colored by condition/library. c Histograms showing the contribution of each library/condition to each cluster. NK natural killer cell, L-endo lymphatic endothelium.

Back to article page